Immunotherapy combinations (unspecified)

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Immunotherapy combinations (unspecified), covering 2025-05-18 to 2025-05-18. Get the full timeline:

Most recent: Clinical Trial Update: Study of Safety and Efficacy of Novel Immunotherapy Combinations in Patients With Triple Negative Breast Cancer (TNBC). [Phase 1]

See pricing